Sowell Financial Services LLC Syros Pharmaceuticals, Inc. Transaction History

Sowell Financial Services LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$5.01 - $7.48 $300 - $448	-60 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$7.19 - $14.95 $431 - $897	60 New	60 $0
Q4 2020 Jan 13, 2021	SELL	$6.66 - $14.66 $1,398 - $3,078	-210 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$8.69 - $14.47 $1,824 - $3,038	210 New	210 $2,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.